| Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label … RW van Der Pluijm, R Tripura, RM Hoglund, AP Phyo, D Lek, A Ul Islam, ... The Lancet 395 (10233), 1345-1360, 2020 | 211 | 2020 |
| The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern R Abdelnabi, CS Foo, D Jochmans, L Vangeel, S De Jonghe, ... Nature Communications 13 (1), 719, 2022 | 111 | 2022 |
| COVID-19 prevention and treatment: a critical analysis of chloroquine and hydroxychloroquine clinical pharmacology NJ White, JA Watson, RM Hoglund, XHS Chan, PY Cheah, J Tarning PLoS medicine 17 (9), e1003252, 2020 | 110 | 2020 |
| Population pharmacokinetic properties of piperaquine in falciparum malaria: an individual participant data meta-analysis RM Hoglund, L Workman, MD Edstein, NX Thanh, NN Quang, I Zongo, ... PLoS medicine 14 (1), e1002212, 2017 | 75 | 2017 |
| Artemether‐lumefantrine co‐administration with antiretrovirals: population pharmacokinetics and dosing implications RM Hoglund, P Byakika‐Kibwika, M Lamorde, C Merry, M Ashton, ... British journal of clinical pharmacology 79 (4), 636-649, 2015 | 55 | 2015 |
| A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan RM Hoglund, I Adam, W Hanpithakpong, M Ashton, N Lindegardh, ... Malaria journal 11, 1-12, 2012 | 46 | 2012 |
| Safety, pharmacokinetics, and mosquito‐lethal effects of ivermectin in combination with dihydroartemisinin‐piperaquine and primaquine in healthy adult Thai subjects KC Kobylinski, P Jittamala, B Hanboonkunupakarn, S Pukrittayakamee, ... Clinical Pharmacology & Therapeutics 107 (5), 1221-1230, 2020 | 40 | 2020 |
| Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label … TJ Peto, R Tripura, JJ Callery, D Lek, HDT Nghia, C Nguon, NTH Thuong, ... The Lancet Infectious Diseases 22 (6), 867-878, 2022 | 32 | 2022 |
| Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin–piperaquine in healthy volunteers P Chotsiri, T Wattanakul, RM Hoglund, B Hanboonkunupakarn, ... British journal of clinical pharmacology 83 (12), 2752-2766, 2017 | 32 | 2017 |
| Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border R Höglund, Y Moussavi, R Ruengweerayut, A Cheomung, A Äbelö, ... Malaria Journal 15, 1-9, 2016 | 32 | 2016 |
| Concentration-dependent mortality of chloroquine in overdose JA Watson, J Tarning, RM Hoglund, FJ Baud, B Megarbane, JL Clemessy, ... Elife 9, e58631, 2020 | 31 | 2020 |
| Primaquine pharmacokinetics in lactating women and breastfed infant exposures ME Gilder, W Hanpithakphong, RM Hoglund, J Tarning, HH Win, N Hilda, ... Clinical Infectious Diseases 67 (7), 1000-1007, 2018 | 31 | 2018 |
| Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria P Chotsiri, L Denoeud‐Ndam, E Baudin, O Guindo, H Diawara, O Attaher, ... Clinical Pharmacology & Therapeutics 106 (6), 1299-1309, 2019 | 28 | 2019 |
| Population pharmacokinetic properties of antituberculosis drugs in Vietnamese children with tuberculous meningitis N Panjasawatwong, T Wattanakul, RM Hoglund, ND Bang, T Pouplin, ... Antimicrobial Agents and Chemotherapy 65 (1), 10.1128/aac. 00487-20, 2020 | 25 | 2020 |
| A randomized controlled trial of three-versus five-day artemether-lumefantrine regimens for treatment of uncomplicated Plasmodium falciparum malaria in pregnancy in Africa MA Onyamboko, RM Hoglund, SJ Lee, C Kabedi, D Kayembe, ... Antimicrobial agents and chemotherapy 64 (3), 10.1128/aac. 01140-19, 2020 | 23 | 2020 |
| Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India BW Aruldhas, RM Hoglund, J Ranjalkar, J Tarning, SK Mathew, ... British journal of clinical pharmacology 85 (3), 644-654, 2019 | 21 | 2019 |
| Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children … M Hamaluba, RW van der Pluijm, J Weya, P Njuguna, M Ngama, ... The Lancet Infectious Diseases 21 (10), 1395-1406, 2021 | 20 | 2021 |
| An individual participant data population pharmacokinetic meta-analysis of drug-drug interactions between lumefantrine and commonly used antiretroviral treatment J Francis, KI Barnes, L Workman, T Kredo, LS Vestergaard, RM Hoglund, ... Antimicrobial agents and chemotherapy 64 (5), 10.1128/aac. 02394-19, 2020 | 17 | 2020 |
| Serial correlation in optimal design for nonlinear mixed effects models J Nyberg, R Höglund, M Bergstrand, MO Karlsson, AC Hooker Journal of pharmacokinetics and pharmacodynamics 39, 239-249, 2012 | 17 | 2012 |
| Pharmacokinetic study of rectal artesunate in children with severe malaria in Africa C Fanello, RM Hoglund, SJ Lee, D Kayembe, P Ndjowo, C Kabedi, ... Antimicrobial Agents and Chemotherapy 65 (4), 10.1128/aac. 02223-20, 2021 | 14 | 2021 |
Joel TarningUniversity of OxfordAdresse e-mail validée de tropmedres.ac
